Mast cells, angiogenesis and cancer

73Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mast cells (MCs) were first described by Paul Ehrlich 1 in his doctoral thesis. MCs have long been implicated in the pathogenesis of allergic reactions and certain protective responses to parasites. As most tumors contain inflammatory cell infiltrates, which often include plentiful MCs, the question as to the possible contribution of MCs to tumor development has progressively been emerging. In this chapter, the specific involvement of MCs in tumor biology and tumor fate will be considered, with particular emphasis on the capacity of these cells to stimulate tumor growth by promoting angiogenesis and lymphangiogenesis. Data from experimental carcinogenesis and from different tumor settings in human pathology will be summarized. Information to be presented will suggest that MCs may serve as a novel therapeutic target for cancer treatment. © 2011 Landes Bioscience and Springer Science+Business Media.

Cite

CITATION STYLE

APA

Ribatti, D., & Crivellato, E. (2011). Mast cells, angiogenesis and cancer. Advances in Experimental Medicine and Biology, 716, 270–288. https://doi.org/10.1007/978-1-4419-9533-9_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free